LSTA
LISATA THERAPEUTICS, INC.
NASDAQ · Healthcare · Biotechnology · US
$1.70
−2.30%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
-51.7%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Jan 13, 2026 | Imam Tariq · officer: SVP, Bus Dev, General Counsel | F-InKind | 1,401 | $1.97 |
| Jan 13, 2026 | Mazzo David J · director, officer: President & CEO | A-Award | 81,000 | $0.00 |
| Jan 13, 2026 | Mazzo David J · director, officer: President & CEO | F-InKind | 10,503 | $1.97 |
| Jan 13, 2026 | Mazzo David J · director, officer: President & CEO | F-InKind | 10,515 | $1.97 |
| Jan 13, 2026 | Mazzo David J · director, officer: President & CEO | F-InKind | 12,224 | $1.97 |
| Jan 13, 2026 | Mazzo David J · director, officer: President & CEO | F-InKind | 7,854 | $1.97 |
| Jan 13, 2026 | Mazzo David J · director, officer: President & CEO | A-Award | 40,000 | $1.97 |
| Jan 13, 2026 | Nisco James · officer: SVP, Fin/Treas, Chief Actg Off | A-Award | 15,000 | $0.00 |
| Jan 13, 2026 | Nisco James · officer: SVP, Fin/Treas, Chief Actg Off | F-InKind | 2,131 | $1.97 |
| Jan 13, 2026 | Nisco James · officer: SVP, Fin/Treas, Chief Actg Off | F-InKind | 1,137 | $1.97 |
| Jan 13, 2026 | Nisco James · officer: SVP, Fin/Treas, Chief Actg Off | F-InKind | 781 | $1.97 |
| Jan 13, 2026 | Nisco James · officer: SVP, Fin/Treas, Chief Actg Off | A-Award | 7,000 | $1.97 |
| Jan 13, 2026 | Imam Tariq · officer: SVP, Bus Dev, General Counsel | A-Award | 15,000 | $0.00 |
| Jan 13, 2026 | Imam Tariq · officer: SVP, Bus Dev, General Counsel | F-InKind | 840 | $1.97 |
| Jan 13, 2026 | Imam Tariq · officer: SVP, Bus Dev, General Counsel | F-InKind | 747 | $1.97 |
| Jan 13, 2026 | Imam Tariq · officer: SVP, Bus Dev, General Counsel | F-InKind | 513 | $1.97 |
| Jan 13, 2026 | Imam Tariq · officer: SVP, Bus Dev, General Counsel | A-Award | 7,000 | $1.97 |
| Jan 13, 2026 | Buck Kristen K · officer: EVP, R&D and CMO | A-Award | 25,000 | $0.00 |
| Jan 13, 2026 | Buck Kristen K · officer: EVP, R&D and CMO | F-InKind | 2,982 | $1.97 |
| Jan 13, 2026 | Buck Kristen K · officer: EVP, R&D and CMO | F-InKind | 3,221 | $1.97 |
| Jan 13, 2026 | Buck Kristen K · officer: EVP, R&D and CMO | F-InKind | 2,147 | $1.97 |
| Jan 13, 2026 | Buck Kristen K · officer: EVP, R&D and CMO | A-Award | 13,000 | $1.97 |
| Jan 13, 2026 | KLOSK STEVEN M · director | A-Award | 30,456 | $0.00 |
| Jan 13, 2026 | HENSON HEIDI · director | A-Award | 30,456 | $0.00 |
| Jan 13, 2026 | Flowers Cynthia Louise · director | A-Award | 30,456 | $0.00 |
| Jan 13, 2026 | BROWN GREGORY B · director | A-Award | 30,456 | $0.00 |
| Jan 13, 2026 | AZAB MOHAMMAD · director | A-Award | 30,456 | $0.00 |
| Jan 13, 2025 | Flowers Cynthia Louise · director | A-Award | 15,789 | $0.00 |
| Jan 13, 2025 | AZAB MOHAMMAD · director | A-Award | 15,789 | $0.00 |
| Jan 13, 2025 | Nisco James · officer: SVP, Fin/Treas, Chief Actg Off | A-Award | 15,000 | $0.00 |
Institutional positioning
13F filings over the trailing two quarters
New 17Increased 14Reduced 9Sold out 6
| Filer | Action | Shares | Filed |
|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | Increased | 278,837 | Aug 13, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 271,815 | May 15, 2026 |
| Yakira Capital Management, Inc. | New Position | 138,561 | Aug 13, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | Increased | 131,715 | May 14, 2026 |
| CSS LLC/IL | Increased | 110,422 | Aug 14, 2026 |
| DELTEC ASSET MANAGEMENT LLC | New Position | 90,000 | Apr 24, 2026 |
| DELTEC ASSET MANAGEMENT LLC | Reduced | 83,197 | Jul 21, 2026 |
| Rangeley Capital, LLC | Increased | 81,000 | Aug 14, 2026 |
| RANGELEY CAPITAL, LLC | New Position | 75,000 | May 15, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 72,632 | Aug 12, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 70,887 | May 15, 2026 |
| CSS LLC/IL | New Position | 61,898 | May 15, 2026 |
| Virtu Financial LLC | Increased | 58,782 | Aug 13, 2026 |
| BlackRock, Inc. | Unchanged | 54,857 | Aug 7, 2026 |
| BLACKROCK, INC. | Unchanged | 54,857 | May 13, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Jan 13, 2026